Paper39403159
Next-generation CRISPR/Cas-based ultrasensitive diagnostic tools: current progress and prospects.
Sahel DK and 7 others. RSC Adv, 2024. Cited by 25 papers, by iCite.
Cite this record
ConductScience Library. Next-generation CRISPR/Cas-based ultrasensitive diagnostic tools: current progress and prospects. Papers, record 39403159. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/39403159
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
- Title
- Next-generation CRISPR/Cas-based ultrasensitive diagnostic tools: current progress and prospects.
- PubMed
Topics0
NLM's MeSH indexing of the paper, its major topics first.
None in this release.
References82
The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.
| Order | PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|---|
| 1 | 29707234 | CRISPR-Cas12a-assisted nucleic acid detection. | Cell Discov | 2018 | https://conductscience.org/library/papers/29707234 | PubMed |
| 2 | 31461619 | CRISPR-Cas12a Coupled with Platinum Nanoreporter for Visual Quantification of SNVs on a Volumetric Bar-Chart Chip. | Anal Chem | 2019 | https://conductscience.org/library/papers/31461619 | PubMed |
| 3 | 31897558 | Rapid and sensitive exosome detection with CRISPR/Cas12a. | Anal Bioanal Chem | 2020 | https://conductscience.org/library/papers/31897558 | PubMed |
| 4 | 29486117 | Highly Effective and Low-Cost MicroRNA Detection with CRISPR-Cas9. | ACS Synth Biol | 2018 | https://conductscience.org/library/papers/29486117 | PubMed |
| 5 | 25981466 | Annotation and Classification of CRISPR-Cas Systems. | Methods Mol Biol | 2015 | https://conductscience.org/library/papers/25981466 | PubMed |
| 6 | 33570401 | Reverse Transcription Recombinase Polymerase Amplification Coupled with CRISPR-Cas12a for Facile and Highly Sensitive Colorimetric SARS-CoV-2 Detection. | Anal Chem | 2021 | https://conductscience.org/library/papers/33570401 | PubMed |
| 7 | 33359413 | CRISPR: A new paradigm of theranostics. | Nanomedicine | 2021 | https://conductscience.org/library/papers/33359413 | PubMed |
| 8 | 33875803 | Amplification-free RNA detection with CRISPR-Cas13. | Commun Biol | 2021 | https://conductscience.org/library/papers/33875803 | PubMed |
| 9 | 18722764 | An indirect competitive immunoassay for insulin autoantibodies based on surface plasmon resonance. | Biosens Bioelectron | 2008 | https://conductscience.org/library/papers/18722764 | PubMed |
| 10 | 30654914 | CRISPR/Cas Systems towards Next-Generation Biosensing. | Trends Biotechnol | 2019 | https://conductscience.org/library/papers/30654914 | PubMed |
| 11 | 26422227 | Cpf1 is a single RNA-guided endonuclease of a class 2 CRISPR-Cas system. | Cell | 2015 | https://conductscience.org/library/papers/26422227 | PubMed |
| 12 | 32349121 | Massively multiplexed nucleic acid detection with Cas13. | Nature | 2020 | https://conductscience.org/library/papers/32349121 | PubMed |
| 13 | 35047828 | Mini review: Recent progress in RT-LAMP enabled COVID-19 detection. | Sens Actuators Rep | 2020 | https://conductscience.org/library/papers/35047828 | PubMed |
| 14 | 29449511 | CRISPR-Cas12a target binding unleashes indiscriminate single-stranded DNase activity. | Science | 2018 | https://conductscience.org/library/papers/29449511 | PubMed |
| 15 | 28562584 | Structure of the Cpf1 endonuclease R-loop complex after target DNA cleavage. | Nature | 2017 | https://conductscience.org/library/papers/28562584 | PubMed |
| 16 | 31532637 | HOLMESv2: A CRISPR-Cas12b-Assisted Platform for Nucleic Acid Detection and DNA Methylation Quantitation. | ACS Synth Biol | 2019 | https://conductscience.org/library/papers/31532637 | PubMed |
| 17 | 30856357 | CRISPR-Cas in Streptococcus pyogenes. | RNA Biol | 2019 | https://conductscience.org/library/papers/30856357 | PubMed |
| 18 | 27718551 | Paired Design of dCas9 as a Systematic Platform for the Detection of Featured Nucleic Acid Sequences in Pathogenic Strains. | ACS Synth Biol | 2017 | https://conductscience.org/library/papers/27718551 | PubMed |
| 19 | 33961413 | Advances in Clustered, Regularly Interspaced Short Palindromic Repeats (CRISPR)-Based Diagnostic Assays Assisted by Micro/Nanotechnologies. | ACS Nano | 2021 | https://conductscience.org/library/papers/33961413 | PubMed |
| 20 | 33346665 | CRISPR-Cas12a-Based Nucleic Acid Amplification-Free DNA Biosensor via Au Nanoparticle-Assisted Metal-Enhanced Fluorescence and Colorimetric Analysis. | Nano Lett | 2021 | https://conductscience.org/library/papers/33346665 | PubMed |
Cited by17
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 25 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 42871210 | An FTA card-based CRISPR/Cas12a platform with isothermal amplification for portable tuberculosis diagnosis. | Front Microbiol | 2026 | https://conductscience.org/library/papers/42871210 | PubMed |
| 42864491 | The global patent landscape of CRISPR-Cas applications in medicine. | Nat Biotechnol | 2026 | https://conductscience.org/library/papers/42864491 | PubMed |
| 42650936 | Advancements in CRISPR/Cas Technologies for Sensitive Cancer Detection: Mechanisms, Platforms, and Clinical Translation Roadmap. | Diagnostics (Basel) | 2026 | https://conductscience.org/library/papers/42650936 | PubMed |
| 42266929 | Artificial intelligence in optimizing antimicrobial therapy for gastro-renal disorders. | Front Cell Infect Microbiol | 2026 | https://conductscience.org/library/papers/42266929 | PubMed |
| 42201448 | CRISPR/Cas‑driven biosensing: molecular mechanisms and advances in diagnostics. | Mol Biol Rep | 2026 | https://conductscience.org/library/papers/42201448 | PubMed |
| 42165978 | Nanomaterial-nucleic acid probe synergy: accelerating rapid pathogen detection and antimicrobial susceptibility testing in bloodstream infections. | Folia Microbiol (Praha) | 2026 | https://conductscience.org/library/papers/42165978 | PubMed |
| 42137166 | Urine-based PSMA detection for noninvasive prostate cancer diagnosis: recent advances, translational challenges, and future perspectives. | Front Oncol | 2026 | https://conductscience.org/library/papers/42137166 | PubMed |
| 41865101 | The evolution of next-generation lateral flow assays for bacterial and fungal diagnostics. | Mikrochim Acta | 2026 | https://conductscience.org/library/papers/41865101 | PubMed |
| 41524947 | Food-borne bacterial pathogens: emerging approaches in detection and prevention. | Arch Microbiol | 2026 | https://conductscience.org/library/papers/41524947 | PubMed |
| 41463005 | Enhanced Detection of SARS-CoV-2 Using Platinum-Decorated Poly(2-vinylpyridine) Nanoparticle-Based Lateral Flow Immunoassay. | Biomedicines | 2025 | https://conductscience.org/library/papers/41463005 | PubMed |
| 40943417 | From Pathophysiology to Innovative Therapies in Eye Diseases: A Brief Overview. | Int J Mol Sci | 2025 | https://conductscience.org/library/papers/40943417 | PubMed |
| 40647454 | Advancing Cholangiocarcinoma Diagnosis: The Role of Liquid Biopsy and CRISPR/Cas Systems in Biomarker Detection. | Cancers (Basel) | 2025 | https://conductscience.org/library/papers/40647454 | PubMed |
| 40572188 | Overview of Microorganisms: Bacterial Microbiome, Mycobiome, Virome Identified Using Next-Generation Sequencing, and Their Application to Ophthalmic Diseases. | Microorganisms | 2025 | https://conductscience.org/library/papers/40572188 | PubMed |
| 40256781 | Rapid molecular detection of Senecavirus A based on reverse transcription loop-mediated isothermal amplification (RT-LAMP) and CRISPR/Cas12a. | Front Bioeng Biotechnol | 2025 | https://conductscience.org/library/papers/40256781 | PubMed |
| 40051500 | Two sides of the same coin: heat shock proteins as biomarkers and therapeutic targets for some complex diseases. | Front Mol Biosci | 2025 | https://conductscience.org/library/papers/40051500 | PubMed |
| 39902531 | CRISPR in clinical diagnostics: bridging the gap between research and practice. | Bioanalysis | 2025 | https://conductscience.org/library/papers/39902531 | PubMed |
| 39880685 | Building the Future of Clinical Diagnostics: An Analysis of Potential Benefits and Current Barriers in CRISPR/Cas Diagnostics. | ACS Synth Biol | 2025 | https://conductscience.org/library/papers/39880685 | PubMed |
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Grants
- Trials
- Comments and corrections
- Genes
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/39403159
GET https://conductscience.org/api/papers/v1/39403159/references?page=2